Statin Use, Lipids, and 3-Hydroxy-3-Methyl-Glutaryl Coenzyme A Reductase Inhibition on Risk of Idiopathic Pulmonary Fibrosis.

Zhao, Sizheng Steven; Alton, Philip; Rogers, Kira; Hughes, David M

Zhao, Sizheng Steven; Alton, Philip; Rogers, Kira; Hughes, David M.

Afiliação

Zhao SS; Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Science, School of Biological Sciences, Faculty of Biological Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom. Electronic address: Sizheng
Alton P; Liverpool University Hospitals National Health Service Foundation Trust, Liverpool, United Kingdom.
Rogers K; Manchester Medical School, The University of Manchester, Manchester, United Kingdom.
Hughes DM; Department of Health Data Science, University of Liverpool, Liverpool, United Kingdom.

Clin Ther ; 46(1): 79-81, 2024 01.

Article em En | MEDLINE | ID: mdl-37978012

Assuntos

Inibidores de Hidroximetilglutaril-CoA Redutases; Fibrose Pulmonar Idiopática; Humanos; Inibidores de Hidroximetilglutaril-CoA Redutases/efeitos adversos; Fibrose Pulmonar Idiopática/tratamento farmacológico; Coenzima A; Oxirredutases; Lipídeos

Palavras-chave

HMG-CoA reductase; LDL cholesterol; Mendelian randomization; idiopathic pulmonary fibrosis; statins

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Fibrose Pulmonar Idiopática Limite: Humans Idioma: En Revista: Clin Ther Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google